Literature DB >> 18221299

Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxide.

W-W Chang1, I-J Su, W-T Chang, W Huang, H-Y Lei.   

Abstract

The role of the p38 mitogen-activated protein kinase (MAPK) pathway in hepatitis B virus (HBV) replication was investigated in this study. After transient transfection with HBV plasmid, p38 MAPK, but not JNK or ERK1/2, was significantly phosphorylated in human hepatoma cell Huh7. Interestingly, HBV proteins and RNA synthesis were significantly inhibited by a specific inhibitor of p38 MAPK, SB203580, in a dose-dependent manner. Intracellular core-associated DNA, extracellular virion-associated DNA and covalently closed circular DNA were also significantly inhibited by SB203580. Further results showed the antiviral role of nitric oxide (NO) on the suppression of HBV replication and downregulation of p38 MAPK phosphorylation. In conclusion, these results suggested that suppression of phosphorylation of p38 MAPK by inhibitor or NO could inhibit intracellular HBV replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221299     DOI: 10.1111/j.1365-2893.2007.00968.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

1.  HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.

Authors:  Qingyu Yang; Qi Zhang; Xuewu Zhang; Lei You; Wenbiao Wang; Weiyong Liu; Yang Han; Chunqiang Ma; Wei Xu; Junbo Chen; Hua Yang; Pin Wan; Yao Zhou; Yingle Liu; Kailang Wu; Ziwen Yang; Jianguo Wu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

2.  An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.

Authors:  So-Young Kim; Hong Kim; Sang-Won Kim; Na-Rae Lee; Chae-Min Yi; Jinyuk Heo; Bum-Joon Kim; Nam-Jung Kim; Kyung-Soo Inn
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.

Authors:  Sabyasachi Bhattacharya; Juan Qian; Christos Tzimas; Darren P Baker; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

4.  Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.

Authors:  Joshua C Johnson; Osvaldo Martinez; Anna N Honko; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  Antiviral Res       Date:  2014-05-09       Impact factor: 5.970

5.  Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells.

Authors:  Lanlan Wei; Patti E Gravitt; Hebin Song; Anastacia M Maldonado; Michelle A Ozbun
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

6.  The role of Misshapen NCK-related kinase (MINK), a novel Ste20 family kinase, in the IRES-mediated protein translation of human enterovirus 71.

Authors:  Shi Yun Leong; Bryan Kit Teck Ong; Justin Jang Hann Chu
Journal:  PLoS Pathog       Date:  2015-03-06       Impact factor: 6.823

7.  Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication.

Authors:  Jinke Pang; Geng Zhang; Yong Lin; Zhanglian Xie; Hongyan Liu; Libo Tang; Mengji Lu; Ran Yan; Haitao Guo; Jian Sun; Jinlin Hou; Xiaoyong Zhang
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

8.  p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation.

Authors:  Yunfei Chen; Lufan Wang; Jiali Jin; Yi Luan; Cong Chen; Yu Li; Hongshang Chu; Xinbo Wang; Guanghong Liao; Yue Yu; Hongqi Teng; Yanming Wang; Weijuan Pan; Lan Fang; Lujian Liao; Zhengfan Jiang; Xin Ge; Bin Li; Ping Wang
Journal:  J Exp Med       Date:  2017-03-02       Impact factor: 14.307

Review 9.  Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection.

Authors:  Jiayi Wang; Lingyao Du; Hong Tang
Journal:  Front Med (Lausanne)       Date:  2021-11-24

Review 10.  Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis.

Authors:  Xiaolin Wang; Qing Xie
Journal:  J Clin Transl Hepatol       Date:  2021-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.